Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 324

1.

APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.

Grams ME, Surapaneni A, Ballew SH, Appel LJ, Boerwinkle E, Boulware LE, Chen TK, Coresh J, Cushman M, Divers J, Gutiérrez OM, Irvin MR, Ix JH, Kopp JB, Kuller LH, Langefeld CD, Lipkowitz MS, Mukamal KJ, Musani SK, Naik RP, Pajewski NM, Peralta CA, Tin A, Wassel CL, Wilson JG, Winkler CA, Young BA, Zakai NA, Freedman BI.

J Am Soc Nephrol. 2019 Aug 5. pii: ASN.2019030240. doi: 10.1681/ASN.2019030240. [Epub ahead of print]

PMID:
31383730
2.

Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.

Lee AK, Katz R, Jotwani V, Garimella PS, Ambrosius WT, Cheung AK, Gren LH, Neyra JA, Punzi H, Raphael KL, Shlipak MG, Ix JH.

Hypertension. 2019 Aug 5:HYPERTENSIONAHA11913339. doi: 10.1161/HYPERTENSIONAHA.119.13339. [Epub ahead of print]

PMID:
31378102
3.

Collagen biomarkers are associated with decline in renal function independently of blood pressure and other cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis Study.

Duprez DA, Gross MD, Ix JH, Peralta CA, Kizer JR, Shea S, Jacobs DR Jr.

J Hypertens. 2019 Jul 26. doi: 10.1097/HJH.0000000000002207. [Epub ahead of print]

PMID:
31356403
4.

Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.

Beddhu S, Shen J, Cheung AK, Kimmel PL, Chertow GM, Wei G, Boucher RE, Chonchol M, Arman F, Campbell RC, Contreras G, Dwyer JP, Freedman BI, Ix JH, Kirchner K, Papademetriou V, Pisoni R, Rocco MV, Whelton PK, Greene T.

J Am Soc Nephrol. 2019 Aug;30(8):1523-1533. doi: 10.1681/ASN.2018121261. Epub 2019 Jul 19.

PMID:
31324734
5.

Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate.

Hallan SI, Rifkin DE, Potok OA, Katz R, Langlo KA, Bansal N, Ix JH.

Kidney Int. 2019 May 10. pii: S0085-2538(19)30484-3. doi: 10.1016/j.kint.2019.04.022. [Epub ahead of print]

PMID:
31301887
6.

The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury.

Bullen AL, Katz R, Lee AK, Anderson CAM, Cheung AK, Garimella PS, Jotwani V, Haley WE, Ishani A, Lash JP, Neyra JA, Punzi H, Rastogi A, Riessen E, Malhotra R, Parikh CR, Rocco MV, Wall BM, Bhatt UY, Shlipak MG, Ix JH, Estrella MM.

Kidney Int. 2019 Aug;96(2):470-479. doi: 10.1016/j.kint.2019.03.024. Epub 2019 May 7.

PMID:
31262489
7.

Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.

Garimella PS, Lee AK, Ambrosius WT, Bhatt U, Cheung AK, Chonchol M, Craven T, Hawfield AT, Jotwani V, Killeen A, Punzi H, Sarnak MJ, Wall BM, Ix JH, Shlipak MG.

Eur Heart J. 2019 Jun 30. pii: ehz392. doi: 10.1093/eurheartj/ehz392. [Epub ahead of print]

PMID:
31257404
8.

Biochemical markers of bone turnover and risk of incident hip fracture in older women: the Cardiovascular Health Study.

Massera D, Xu S, Walker MD, Valderrábano RJ, Mukamal KJ, Ix JH, Siscovick DS, Tracy RP, Robbins JA, Biggs ML, Xue X, Kizer JR.

Osteoporos Int. 2019 Jun 21. doi: 10.1007/s00198-019-05043-1. [Epub ahead of print]

PMID:
31227885
9.

Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial.

Malhotra R, Katz R, Weiner DE, Levey AS, Cheung AK, Bostom AG, Ix JH.

Am J Hypertens. 2019 Aug 14;32(9):816-823. doi: 10.1093/ajh/hpz095.

PMID:
31179500
10.

Association of Serum Uromodulin With ESKD and Kidney Function Decline in the Elderly: The Cardiovascular Health Study.

Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, Chaves PHM, Shlipak MG, Bansal N, Sarnak MJ.

Am J Kidney Dis. 2019 May 22. pii: S0272-6386(19)30664-X. doi: 10.1053/j.ajkd.2019.02.024. [Epub ahead of print]

PMID:
31128770
11.

Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.

Ix JH, Isakova T, Larive B, Raphael KL, Raj DS, Cheung AK, Sprague SM, Fried LF, Gassman JJ, Middleton JP, Flessner MF, Block GA, Wolf M.

J Am Soc Nephrol. 2019 Jun;30(6):1096-1108. doi: 10.1681/ASN.2018101058. Epub 2019 May 13.

PMID:
31085679
12.

Advanced glycation end product carboxymethyl-lysine and risk of incident peripheral artery disease in older adults: The Cardiovascular Health Study.

Garg PK, Biggs ML, Barzilay J, Djousse L, Hirsch C, Ix JH, Kizer JR, Tracy RP, Newman AB, Siscovick DS, Mukamal KJ.

Diab Vasc Dis Res. 2019 Sep;16(5):483-485. doi: 10.1177/1479164119847481. Epub 2019 May 8.

PMID:
31064218
13.

Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis.

Bortnick AE, Xu S, Kim RS, Kestenbaum B, Ix JH, Jenny NS, de Boer IH, Michos ED, Thanassoulis G, Siscovick DS, Budoff MJ, Kizer JR.

Atherosclerosis. 2019 Jun;285:79-86. doi: 10.1016/j.atherosclerosis.2019.04.215. Epub 2019 Apr 13.

PMID:
31048102
14.

Clearance of FGF-23 during continuous renal replacement therapy.

Sharma S, Christov M, Ix JH, Waikar SS.

Hemodial Int. 2019 Jul;23(3):366-368. doi: 10.1111/hdi.12758. Epub 2019 Apr 30.

PMID:
31037817
15.

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Cheung AK, Chang TI, Cushman WC, Furth SL, Ix JH, Pecoits-Filho R, Perkovic V, Sarnak MJ, Tobe SW, Tomson CRV, Cheung M, Wheeler DC, Winkelmayer WC, Mann JFE; Conference Participants.

Kidney Int. 2019 May;95(5):1027-1036. doi: 10.1016/j.kint.2018.12.025.

16.

Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.

Jotwani VK, Lee AK, Estrella MM, Katz R, Garimella PS, Malhotra R, Rifkin DE, Ambrosius W, Freedman BI, Cheung AK, Raphael KL, Drawz P, Neyra JA, Oparil S, Punzi H, Shlipak MG, Ix JH; for the SPRINT Research Group.

Am J Nephrol. 2019;49(5):346-355. doi: 10.1159/000499531. Epub 2019 Apr 2.

PMID:
30939472
17.

Association of serum uromodulin with mortality and cardiovascular disease in the elderly-the Cardiovascular Health Study.

Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, Chaves PHM, Shlipak MG, Bansal N, Sarnak MJ.

Nephrol Dial Transplant. 2019 Mar 21. pii: gfz008. doi: 10.1093/ndt/gfz008. [Epub ahead of print]

PMID:
30903163
18.

Correlates of T50 and relationships with bone mineral density in community-living older men: the osteoporotic fractures in men (MrOS) study.

Bullen AL, Anderson CAM, Hooker ER, Kado DM, Orwoll E, Pasch A, Ix JH.

Osteoporos Int. 2019 Jul;30(7):1529-1531. doi: 10.1007/s00198-019-04925-8. Epub 2019 Mar 18.

PMID:
30887076
19.

Implications of Oxalate as a Novel Risk Factor for Chronic Kidney Disease.

Ix JH.

JAMA Intern Med. 2019 Apr 1;179(4):551-552. doi: 10.1001/jamainternmed.2018.7987. No abstract available.

PMID:
30830214
20.

Is Metabolic Acidosis a Friend or Foe for Cardiovascular Disease in Kidney Transplant Recipients?

Woodell TB, Ix JH.

Am J Kidney Dis. 2019 Apr;73(4):465-466. doi: 10.1053/j.ajkd.2019.01.006. Epub 2019 Feb 14. No abstract available.

PMID:
30773237
21.

The association of the ankle-brachial index, the toe-brachial index, and their difference, with mortality and limb outcomes in dialysis patients.

Prasad R, Kamath T, Ginsberg C, Potok OA, Ix JH, Garimella PS, Rifkin DE.

Hemodial Int. 2019 Apr;23(2):214-222. doi: 10.1111/hdi.12734. Epub 2019 Feb 8.

PMID:
30734987
22.

Models and Studies of Aging: Executive Summary of a Report from the U13 Conference Series.

Hurria A, Carpenter CR, McFarland F, Lundebjerg NE, de Cabo R, Ferrucci L, Studenski SA, Barzilai N, Briggs JP, Ix JH, Kitzman DW, Kuchel GA, Musi N, Newman JC, Rando TA, Smith AK, Walston JD, Kirkland JL, Yung R.

J Am Geriatr Soc. 2019 Mar;67(3):428-433. doi: 10.1111/jgs.15788. Epub 2019 Jan 29.

PMID:
30693953
23.

Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD.

Prasad PV, Li W, Raj DS, Carr J, Carr M, Thacker J, Li LP, Wang C, Sprague SM, Ix JH, Chonchol M, Block G, Cheung AK, Raphael K, Gassman J, Wolf M, Fried LF, Isakova T; CKD Optimal Management with BInders and NicotinamidE (COMBINE) study group.

Kidney Int Rep. 2018 Jul 7;3(6):1467-1472. doi: 10.1016/j.ekir.2018.07.006. eCollection 2018 Nov. No abstract available.

24.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1816-1824. doi: 10.2215/CJN.05390518. Epub 2018 Nov 13.

PMID:
30425104
25.

Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.

Zhang WR, Craven TE, Malhotra R, Cheung AK, Chonchol M, Drawz P, Sarnak MJ, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Ann Intern Med. 2018 Nov 6;169(9):610-618. doi: 10.7326/M18-1037. Epub 2018 Oct 23.

PMID:
30357395
26.

Collagen Biomarkers and Incidence of New Onset of Atrial Fibrillation in Subjects With No Overt Cardiovascular Disease at Baseline.

Duprez DA, Heckbert SR, Alonso A, Gross MD, Ix JH, Kizer JR, Tracy RP, Kronmal R, Jacobs DR Jr.

Circ Arrhythm Electrophysiol. 2018 Oct;11(10):e006557. doi: 10.1161/CIRCEP.118.006557.

PMID:
30354407
27.

Association of Fibroblast Growth Factor-23 (FGF-23) With Incident Frailty in HIV-Infected and HIV-Uninfected Individuals.

Wang R, Shlipak MG, Ix JH, Brown TT, Jacobson LP, Palella FJ Jr, Lake JE, Koletar SL, Semba RD, Estrella MM.

J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):118-125. doi: 10.1097/QAI.0000000000001868.

PMID:
30299347
28.

Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.

Malhotra R, Craven T, Ambrosius WT, Killeen AA, Haley WE, Cheung AK, Chonchol M, Sarnak M, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Am J Kidney Dis. 2019 Jan;73(1):21-30. doi: 10.1053/j.ajkd.2018.07.015. Epub 2018 Oct 2.

PMID:
30291012
29.

Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants.

Nadkarni GN, Chauhan K, Rao V, Ix JH, Shlipak MG, Parikh CR, Coca SG.

Am J Kidney Dis. 2019 Jan;73(1):31-38. doi: 10.1053/j.ajkd.2018.07.016. Epub 2018 Oct 2.

PMID:
30291011
30.

Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.

Robinson-Cohen C, Bartz TM, Lai D, Ikizler TA, Peacock M, Imel EA, Michos ED, Foroud TM, Akesson K, Taylor KD, Malmgren L, Matsushita K, Nethander M, Eriksson J, Ohlsson C, Mellström D, Wolf M, Ljunggren O, McGuigan F, Rotter JI, Karlsson M, Econs MJ, Ix JH, Lutsey PL, Psaty BM, de Boer IH, Kestenbaum BR.

J Am Soc Nephrol. 2018 Oct;29(10):2583-2592. doi: 10.1681/ASN.2018020192. Epub 2018 Sep 14.

PMID:
30217807
31.

Chronic Kidney Disease Is Associated With Greater Bone Marrow Adiposity.

Woods GN, Ewing SK, Sigurdsson S, Kado DM, Ix JH, Hue TF, Eiriksdottir G, Xu K, Gudnason V, Lang TF, Vittinghoff E, Harris TB, Rosen CJ, Li X, Schwartz AV.

J Bone Miner Res. 2018 Dec;33(12):2158-2164. doi: 10.1002/jbmr.3562. Epub 2018 Aug 27.

PMID:
30075054
32.

Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.

Weiner DE, Park M, Tighiouart H, Joseph AA, Carpenter MA, Goyal N, House AA, Hsu CY, Ix JH, Jacques PF, Kew CE, Kim SJ, Kusek JW, Pesavento TE, Pfeffer MA, Smith SR, Weir MR, Levey AS, Bostom AG.

Am J Kidney Dis. 2019 Jan;73(1):51-61. doi: 10.1053/j.ajkd.2018.05.015. Epub 2018 Jul 20.

PMID:
30037726
33.

Acute Declines in Renal Function during Intensive BP Lowering and Long-Term Risk of Death.

Ku E, Ix JH, Jamerson K, Tangri N, Lin F, Gassman J, Smogorzewski M, Sarnak MJ.

J Am Soc Nephrol. 2018 Sep;29(9):2401-2408. doi: 10.1681/ASN.2018040365. Epub 2018 Jul 13.

PMID:
30006417
34.

Biochemical Markers of Bone Turnover and Risk of Incident Diabetes in Older Women: The Cardiovascular Health Study.

Massera D, Biggs ML, Walker MD, Mukamal KJ, Ix JH, Djousse L, Valderrábano RJ, Siscovick DS, Tracy RP, Xue X, Kizer JR.

Diabetes Care. 2018 Sep;41(9):1901-1908. doi: 10.2337/dc18-0849. Epub 2018 Jul 12.

PMID:
30002202
35.

Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.

Bostom A, Pasch A, Madsen T, Roberts MB, Franceschini N, Steubl D, Garimella PS, Ix JH, Tuttle KR, Ivanova A, Shireman T, Gohh R, Merhi B, Jarolim P, Kusek JW, Pfeffer MA, Liu S, Eaton CB.

Am J Nephrol. 2018;48(1):21-31. doi: 10.1159/000491025. Epub 2018 Jul 11.

PMID:
29996127
36.

Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study.

Selamet U, Katz R, Ginsberg C, Rifkin DE, Fried LF, Kritchevsky SB, Hoofnagle AN, Bibbins-Domingo K, Drew D, Harris T, Newman A, Gutiérrez OM, Sarnak MJ, Shlipak MG, Ix JH.

Am J Kidney Dis. 2018 Sep;72(3):419-428. doi: 10.1053/j.ajkd.2018.03.026. Epub 2018 Jun 6.

PMID:
29885925
37.

Collagen biomarkers predict new onset of hypertension in normotensive participants: the Multi-Ethnic Study of Atherosclerosis.

Duprez DA, Gross MD, Ix JH, Kizer JR, Tracy RP, Shea S, Jacobs DR Jr.

J Hypertens. 2018 Nov;36(11):2245-2250. doi: 10.1097/HJH.0000000000001793.

PMID:
29782392
38.

Evaluating the Use of KIM-1 in Drug Development and Research Following FDA Qualification.

Chen R, Sanyal S, Thompson A, Ix JH, Haskins K, Muldowney L, Amur S.

Clin Pharmacol Ther. 2018 Dec;104(6):1175-1181. doi: 10.1002/cpt.1093. Epub 2018 May 15.

PMID:
29761868
39.

Serum Uromodulin: A Biomarker of Long-Term Kidney Allograft Failure.

Bostom A, Steubl D, Garimella PS, Franceschini N, Roberts MB, Pasch A, Ix JH, Tuttle KR, Ivanova A, Shireman T, Kim SJ, Gohh R, Weiner DE, Levey AS, Hsu CY, Kusek JW, Eaton CB.

Am J Nephrol. 2018;47(4):275-282. doi: 10.1159/000489095. Epub 2018 Apr 26.

PMID:
29698955
40.

Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.

Beddhu S, Greene T, Boucher R, Cushman WC, Wei G, Stoddard G, Ix JH, Chonchol M, Kramer H, Cheung AK, Kimmel PL, Whelton PK, Chertow GM.

Lancet Diabetes Endocrinol. 2018 Jul;6(7):555-563. doi: 10.1016/S2213-8587(18)30099-8. Epub 2018 Apr 21.

41.

Annularity of Aorto-Iliac Arterial Calcification and Risk of All-Cause and Cardiovascular Mortality.

Hendriks EJE, de Jong PA, Beulens JWJ, van der Schouw YT, Forbang NI, Wright CM, Criqui MH, Allison MA, Ix JH.

JACC Cardiovasc Imaging. 2018 Nov;11(11):1718-1719. doi: 10.1016/j.jcmg.2018.01.029. Epub 2018 Apr 18. No abstract available.

PMID:
29680342
42.

Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.

Drew DA, Katz R, Kritchevsky S, Ix JH, Shlipak MG, Newman AB, Hoofnagle A, Fried L, Sarnak MJ, Gutierrez OM.

Am J Nephrol. 2018;47(4):242-250. doi: 10.1159/000488361. Epub 2018 Apr 5.

43.

Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders.

Jotwani V, Katz R, Ix JH, Gutiérrez OM, Bennett M, Parikh CR, Cummings SR, Sarnak MJ, Shlipak MG.

Am J Kidney Dis. 2018 Aug;72(2):205-213. doi: 10.1053/j.ajkd.2017.12.013. Epub 2018 Mar 27.

44.

Correlation of Urine Ammonium and Urine Osmolal Gap in Kidney Transplant Recipients.

Raphael KL, Ix JH.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):638-640. doi: 10.2215/CJN.13311117. Epub 2018 Mar 8. No abstract available.

45.

Measurements of 24-Hour Urinary Sodium and Potassium Excretion: Importance and Implications.

Ix JH, Anderson CAM.

JAMA. 2018 Mar 27;319(12):1201-1202. doi: 10.1001/jama.2018.1153. No abstract available.

PMID:
29516102
46.

Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi-Ethnic Study of Atherosclerosis).

Duprez DA, Gross MD, Kizer JR, Ix JH, Hundley WG, Jacobs DR Jr.

J Am Heart Assoc. 2018 Feb 23;7(5). pii: e007885. doi: 10.1161/JAHA.117.007885.

47.

An exploratory factor analysis of inflammatory and coagulation markers associated with femoral artery atherosclerosis in the San Diego Population Study.

Egnot NS, Barinas-Mitchell E, Criqui MH, Allison MA, Ix JH, Jenny NS, Wassel CL.

Thromb Res. 2018 Apr;164:9-14. doi: 10.1016/j.thromres.2018.02.003. Epub 2018 Feb 13.

48.

Serum Sodium and Cognition in Older Community-Dwelling Men.

Nowak KL, Yaffe K, Orwoll ES, Ix JH, You Z, Barrett-Connor E, Hoffman AR, Chonchol M.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):366-374. doi: 10.2215/CJN.07400717. Epub 2018 Feb 8.

49.

Metabolic Clusters and Outcomes in Older Adults: The Cardiovascular Health Study.

Mukamal KJ, Siscovick DS, de Boer IH, Ix JH, Kizer JR, Djoussé L, Fitzpatrick AL, Tracy RP, Boyko EJ, Kahn SE, Arnold AM.

J Am Geriatr Soc. 2018 Feb;66(2):289-296. doi: 10.1111/jgs.15205.

50.

Progression of calcium density in the ascending thoracic aorta is inversely associated with incident cardiovascular disease events.

Thomas IC, McClelland RL, Allison MA, Ix JH, Michos ED, Forbang NI, Post WS, Wong ND, Budoff MJ, Criqui MH.

Eur Heart J Cardiovasc Imaging. 2018 Dec 1;19(12):1343-1350. doi: 10.1093/ehjci/jey007.

PMID:
29415207

Supplemental Content

Support Center